Document is current
Any future updates will be listed below
-
Authors
Danics, Krisztina
Forrest, Shelley L.
Kovacs, Gabor G.
-
Funding
Funding for this research was provided by:
National Health and Medical Research Council of Australia Ideas grant (214090508)
Rossy Family Foundation
- License Information
-
More Information
Article History
Received: 14 March 2025
Revised: 14 March 2025
Accepted: 15 March 2025
First Online: 25 March 2025
Declarations
:
: SLF receives funding from the National Health and Medical Research Council, Australia outside the submitted work. GGK reports personal fees from Biogen, Parexel, Ferrer, Mitsubishi Tanabe, other funding from Rossy Family Foundation, from Edmond Safra Foundation, grants from Krembil Foundation, MSA Coalition, MJ Fox Foundation, Parkinson Canada, NIH, CurePSP, Canada Foundation for Innovation, and Ontario Research Fund outside the submitted work; in addition, GGK has a shared patent for 5G4 Synuclein antibody and a pending patent for Diagnostic assays for movement disorders (18/537,455), and received royalties from Wiley, Cambridge, and Elsevier publishers. GGK is member of the Acta Neuropathologica Editorial Board but was not involved in the editorial handling of this article. KD does not have interest to report.
